Loomis Sayles & CO L P Aerie Pharmaceuticals Inc Transaction History

Loomis Sayles & CO L P

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$11.32 - $16.63 $21.2 Million - $31.1 Million	-1,872,070 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$15.16 - $18.97 $576,534 - $721,429	-38,030 Reduced 1.99%	1,872,070 $30 Million
Q1 2021 May 17, 2021	SELL	$13.12 - $20.9 $80,596 - $128,388	-6,143 Reduced 0.32%	1,910,100 $34.1 Million
Q4 2020 Feb 12, 2021	SELL	$9.12 - $14.49 $99,845 - $158,636	-10,948 Reduced 0.57%	1,916,243 $25.9 Million
Q3 2020 Nov 12, 2020	BUY	$10.46 - $14.46 $7.8 Million - $10.8 Million	745,413 Added 63.08%	1,927,191 $22.7 Million
Q2 2020 Aug 14, 2020	BUY	$12.0 - $16.13 $14.2 Million - $19.1 Million	1,181,778 New	1,181,778 $17.4 Million
Q4 2018 Feb 14, 2019	SELL	$33.0 - $60.04 $12.3 Million - $22.3 Million	-371,215 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$56.15 - $73.9 $3.81 Million - $5.02 Million	67,871 Added 22.37%	371,215 $22.8 Million
Q2 2018 Aug 14, 2018	BUY	$47.85 - $70.45 $1.71 Million - $2.51 Million	35,672 Added 13.33%	303,344 $20.5 Million
Q1 2018 May 11, 2018	SELL	$51.15 - $61.0 $463,316 - $552,538	-9,058 Reduced 3.27%	267,672 $14.5 Million
Q4 2017 Feb 14, 2018	SELL	$50.85 - $65.1 $75,207 - $96,282	-1,479 Reduced 0.53%	276,730 $16.5 Million
Q3 2017 Nov 14, 2017	BUY	$48.6 - $60.1 $13.5 Million - $16.7 Million	278,209	278,209 $13.5 Million

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

Stay updated on Loomis Sayles & CO L P with notifications on news.